FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA

World Journal of Surgical Oncology

Volumn 5, Issue , 2007, Pages

  Sarikaya, Ismet ^a   Bloomston, Mark ^a,b   Povoski, Stephen P ^a,b   Zhang, Jun ^a   Hall, Nathan C ^a   Knopp, Michael V ^a   Martin Jr , Edward W ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BIBLIOGRAPHIC DATABASE; BONE METASTASIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; COLON ADENOCARCINOMA; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; RECTUM CARCINOMA; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; COLORECTAL TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 34347217896     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-5-64     Document Type: Article

References (33)

1. Jemal A Siegel R Ward E Murray T Xu J Thun MJ Cancer statistics, 2007 CA Cancer J Clin 2007 57 43-66 17237035
2. Zervos EE Badgwell BD Burak WE Jr Arnold MW Martin EW Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup Surgery 2001 130 636-643 10.1067/ msy.2001.116919 11602894
3. Flamen P Hoekstra OS Homans F Van Cutsem E Maes A Stroobants S Peeters M Penninckx F Filez L Bleichrodt RP Mortelmans L Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: The utility of positron emission tomography (PET) Eur J Cancer 2001 37 862-869 10.1016/S0959-8049(01)00049-1 11313174
4. Maldonado A Sancho F Cerdan J Lozano A Mohedano N Jimenez J Moya F Zomeno M 16. FDG-PET in the Detection of Recurrence in Colorectal Cancer Based on Rising CEA Level. Experience in 72 Patients Clin Positron Imaging 2000 3 170 10.1016/S1095-0397(00)00082-0
5. Flanagan FL Dehdashti F Ogunbiyi OA Kodner IJ Siegel BA Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer Ann Surg 1998 227 319-323 1191267 9527052 10.1097/ 00000658-199803000-00001
6. Arulampalam T Costa D Visvikis D Boulos P Taylor I Ell P The impact of FDG-PET on the management algorithm for recurrent colorectal cancer Eur J Nucl Med 2001 28 1758-1765 10.1007/s002590100646 11734912
7. Hung GU Shiau YC Tsai SC Chao TH Ho YJ Kao CH Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer Anticancer Res 2001 21 1375-1378 11396217
8. Whiteford MH Whiteford HM Yee LF Ogunbiyi OA Dehdashti F Siegel BA Birnbaum EH Fleshman JW Kodner IJ Read TE Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum Dis Colon Rectum 2000 43 759-767 10.1007/BF02238010 10859074
9. Valk PE Abella-Columna E Haseman MK Pounds TR Tesar RD Myers RW Greiss HB Hofer GA Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer Arch Surg 1999 134 503-511 10.1001/archsurg.134.5.503 10323422
10. Ogunbiyi OA Flanagan FL Dehdashti F Siegel BA Trask DD Birnbaum EH Fleshman JW Read TE Philpott GW Kodner IJ Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography Ann Surg Oncol 1997 4 613-620 10.1007/BF02303744 9416407
11. Delbeke D Vitola JV Sandler MP Arildsen RC Powers TA Wright JK Jr Chapman WC Pinson CW Staging recurrent metastatic colorectal carcinoma with PET J Nucl Med 1997 38 1196-1201 9255148
12. Galandiuk S Wieand HS Moertel CG Cha SS Fitzgibbons RJ Jr Pemberton JH Wolff BG Patterns of recurrence after curative resection of carcinoma of the colon and rectum Surg Gynecol Obstet 1992 174 27-32 1729745
13. Cass AW Million RR Pfaff WW Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum Cancer 1976 37 2861-2865 10.1002/ 1097-0142(197606)37:6<2861::AID-CNCR2820370643>3.0.CO;2-3 949706
14. Olson RM Perencevich NP Malcolm AW Chaffey JT Wilson RE Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum Cancer 1980 45 2969-2974 10.1002/ 1097-0142(19800615)45:12<2969::AID-CNCR2820451214>3.0.CO;2-7 7388740
15. Turk PS Wanebo HJ Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma Cancer 1993 15 Suppl 4267-4277 10.1002/ 1097-0142(19930615)71:12+<4267::AID-CNCR2820711816>3.0.CO;2-O
16. Pilipshen SJ Heilweil M Quan SH Sternberg SS Enker WE Patterns of pelvic recurrence following definitive resections of rectal cancer Cancer 1984 53 1354-1362 10.1002/ 1097-0142(19840315)53:6<1354::AID-CNCR2820530623>3.0.CO;2-J 6692324
17. Welch JP Donaldson GA Detection and treatment of recurrent cancer of the colon and rectum Am J Surg 1978 135 505-511 10.1016/0002-9610(78)90028-4 637196
18. Gunderson LL Sosin H Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy Cancer 1974 34 1278-1292 10.1002/ 1097-0142(197410)34:4<1278::AID-CNCR2820340440>3.0.CO;2-F 4424091
19. Rao AR Kagan AR Chan PM Gilbert HA Nussbaum H Hintz BL Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon Cancer 1981 48 1492-1495 10.1002/ 1097-0142(19810915)48:6<1492::AID-CNCR2820480636>3.0.CO;2-K 7272970
20. Rich T Gunderson LL Lew R Galdibini JJ Cohen AM Donaldson G Patterns of recurrence of rectal cancer after potentially curative surgery Cancer 1983 52 1317-1329 10.1002/ 1097-0142(19831001)52:7<1317::AID-CNCR2820520731>3.0.CO;2-6 6192900
21. Kelly CJ Daly JM Colorectal cancer. Principles of postoperative follow-up Cancer 1992 70 1397-1408 10.1002/1097-0142(19920901)70:3+ 97::AID-CNCR2820701531>3.0.CO;2-A 1511391
22. Moertel CG Schutt AJ Go VL Carcinoembryonic antigen test for recurrent colorectal carcinoma. Inadequacy for early detection JAMA 1978 239 1065-1066 10.1001/jama.239.11.1065 628054
23. Moertel CG Fleming TR Macdonald JS Haller DG Laurie JA Tangen C An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer JAMA 1993 270 943-947 10.1001/ jama.270.8.943 8141873
24. Burt BM Humm JL Kooby DA Squire OD Mastorides S Larson SM Fong Y Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer Neoplasia 2001 3 189-195 1505592 11494112 10.1038/sj.neo.7900147
25. Huebner RH Park KC Shepherd JE Schwimmer J Czernin J Phelps ME Gambhir SS A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer J Nucl Med 2000 41 1177-1189 10914907
26. Takeuchi O Saito N Koda K Sarashina H Nakajima N Clinical assessment of positron emission tomography for the diagnosis of local recurrence in colorectal cancer Br J Surg 1999 86 932-937 10.1046/ j.1365-2168.1999.01178.x 10417568
27. Schiepers C Penninckx F De Vadder N Merckx E Mortelmans L Bormans G Marchal G Filez L Aerts R Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging Eur J Surg Oncol 1995 21 517-522 10.1016/S0748-7983(95)97046-0 7589597
28. Sahani DV Kalva SP Fischman AJ Kadavigere R Blake M Hahn PF Saini S Detection of liver metastases from adenocarcinoma of the colon and pancreas: Comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET Am J Roentgenol 2005 185 239-246
29. Staib L Schirrmeister H Reske SN Beger HG Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 2000 180 1-5 10.1016/ S0002-9610(00)00406-2 11036130
30. Votrubova J Belohlavek O Jaruskova M Oliverius M Lohynska R Trskova K Sedlackova E Lipska L Stahalova V The role of FDG-PET/CT in the detection of recurrent colorectal cancer Eur J Nucl Med Mol Imaging 2006 33 779-784 10.1007/s00259-006-0072-z 16565845
31. Even-Sapir E Parag Y Lerman H Gutman M Levine C Rabau M Figer A Metser U Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection Radiology 2004 232 815-822 10.1148/radiol.2323031065 15273334
32. Gutman F Alberini JL Wartski M Vilain D Le Stanc E Sarandi F Corone C Tainturier C Pecking AP Incidental colonic focal lesions detected by FDG PET/CT AJR 2005 185 495-500 10.2214/AJR.04.1654 16037527
33. Schoder H Herrmann K Gonen M Hricak H Eberhard S Scardino P Scher HI Larson SM 2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy Clin Cancer Res 2005 11 4761 4769 10.1158/1078-0432.CCR-05-0249 16000572